Published in J Pharm Pharmacol on December 01, 1975
A model of gastric emptying using paracetamol absorption in intensive care patients. Intensive Care Med (1997) 2.23
Determination of nanogram quantities of chlorpromazine and some of its metabolites in plasma using gas-liquid chromatography with an electron capture detector. Anal Chem (1968) 1.80
Electrophysiological indicator of awakening from coma. Lancet (1993) 1.61
Clinical and biochemical comparison of clorazepate and diazepam. Psychol Med (1974) 1.46
Double-blind, randomized study of the effect of cisapride on gastric emptying in critically ill patients. Crit Care Med (1997) 1.46
Influence of posture on plasma nitroglycerin. Br J Clin Pharmacol (1985) 1.45
Chlorpromazine: concentrations in plasma, excretion in urine and duration of effect. Proc R Soc Med (1971) 1.43
A controlled clinical trial of dichloroacetate for treatment of lactic acidosis in adults. The Dichloroacetate-Lactic Acidosis Study Group. N Engl J Med (1992) 1.42
Factors affecting chlorpromazine plasma levels in psychiatric patients. Arch Gen Psychiatry (1970) 1.42
Uptake of disodium cromoglycate in obstructive airways disease. Clin Allergy (1973) 1.38
Natural history and course of acquired lactic acidosis in adults. DCA-Lactic Acidosis Study Group. Am J Med (1994) 1.38
Physiologic and clinical effects of chlorpromazine and their relationship to plasma level. Clin Pharmacol Ther (1973) 1.36
Plasma protein binding of chlorpromazine. J Pharm Pharmacol (1970) 1.30
Plasma levels of chlorpromazine and some of its relatively non-polar metabolites in psychiatric patients. Life Sci (1968) 1.29
Studies of delayed-action medication. V. Plasma levels and urinary excretion of four different dosage forms of chlorpromazine. Clin Pharmacol Ther (1970) 1.28
The physiological disposition of chlorpromazine in the rat and dog. Proc Soc Exp Biol Med (1970) 1.28
Plasma concentrations in the monkey (Macaca mulatta) of six related benzodiazepines after intraperitoneal injection [proceedings]. Br J Pharmacol (1976) 1.24
Treatment of lactic acidosis with dichloroacetate. N Engl J Med (1983) 1.11
Plasma-trifluoperazine concentrations during high dose therapy. Lancet (1981) 1.01
Preparation and stability of indomethacin solutions. Can J Physiol Pharmacol (1982) 1.00
Plasma concentrations and metabolic effects of intravenous sodium dichloroacetate. Clin Pharmacol Ther (1985) 1.00
Plasma disappearance and cerebral effects of chlorpromazine in cirrhosis. Clin Sci (1972) 0.99
Destruction of chlorpromazine during absorption in the rat in vivo and in vitro. Br J Pharmacol (1971) 0.99
Dietary enrichment with omega-3 polyunsaturated fatty acids reverses age-related decreases in the GluR2 and NR2B glutamate receptor subunits in rat forebrain. Neurobiol Aging (2006) 0.96
Chlorpromazine plasma levels and effects. Arch Gen Psychiatry (1970) 0.93
Imipramine and phenelzine decrease glutamate overflow in the prefrontal cortex--a possible mechanism of neuroprotection in major depression? Neuroscience (2000) 0.93
Amikacin sulfate in mares: pharmacokinetics and body fluid and endometrial concentrations after repeated intramuscular administration. Am J Vet Res (1984) 0.92
Nitroglycerin levels after administration via transdermal therapeutic system or nitroglycerin ointment. Lancet (1984) 0.92
In vivo metabolism and clearance of substance P and co-expressed tachykinins in rat striatum. Neuroscience (2002) 0.92
Disposition of glutethimide in man. Clin Pharmacol Ther (1971) 0.92
Effect of dose and ointment application technique on nitroglycerin plasma concentrations. Pharmacotherapy (1983) 0.91
Event-related potentials--neurophysiological tools for predicting emergence and early outcome from traumatic coma. Intensive Care Med (1996) 0.91
Interaction of glutethimide and phenobarbitone with ethanol in man. J Pharm Pharmacol (1972) 0.91
Methods for study of fluphenazine kinetics in man. J Pharm Pharmacol (1976) 0.91
Letter: A note on the analysis of disodium cromoglycate (Intal) in human urine. J Pharm Pharmacol (1973) 0.90
Destruction of chlorpromazine during absorption by rat intestine in vitro. Br J Pharmacol (1970) 0.89
Chronic toxicity of dichloroacetate: possible relation to thiamine deficiency in rats. Fundam Appl Toxicol (1990) 0.88
Double-blind trial of fluphenazine decanoate. Lancet (1972) 0.88
The physiological disposition of 2(2,6-dichloroanilino)-2-imidazoline (St-155). Biochem Pharmacol (1969) 0.88
Pharmacokinetics of closely related benzodiazepines. Br J Clin Pharmacol (1979) 0.88
Acute tolerance to a sedative in man. Br J Pharmacol (1970) 0.88
Theoretical changes in drug distribution resulting from changes in binding to plasma proteins and to tissues. J Pharm Pharmacol (1970) 0.87
Behavioural and pharmacokinetic studies in the monkey (Macaca mulatta) with diazepam, nordiazepam and related 1,4-benzodiazepines. Br J Pharmacol (1977) 0.87
Proceedings: Clinical pharmacology of chlorpromazine. Br J Pharmacol (1972) 0.87
Plasma-fluphenazine concentrations after injection of long-acting esters. Lancet (1978) 0.86
Relative bioavailability of trimeprazine tablets investigated in man using HPLC with electrochemical detection. J Pharm Pharmacol (1986) 0.85
Clinical effects and metabolism of diazepam in patients with chronic liver disease. Clin Sci (Lond) (1982) 0.84
Bioavailability of oral physostigmine. N Engl J Med (1985) 0.84
Pharmacokinetics of dichloroacetate in adult patients with lactic acidosis. J Clin Pharmacol (1997) 0.84
Improved EMIT analysis for lidocaine. Clin Chem (1985) 0.84
Long-acting phenothiazines in schizophrenia. Br Med J (1971) 0.83
The form and distribution of auditory evoked potentials and CNVs when stimuli and responses are lateralized. Prog Brain Res (1980) 0.83
Trials of lithium, chlorpromazine and amitriptyline in schizoaffective patients. Br J Psychiatry (1978) 0.83
Bratton-Marshall and liquid-chromatographic methods compared for determination of sulfamethazine acetylator status. Clin Chem (1981) 0.83
Concentration-effect relationships with major and minor tranquilizers. Clin Pharmacol Ther (1974) 0.83
Kinetics of fluphenazine after fluphenazine dihydrochloride, enanthate and decanoate administration to man. Br J Clin Pharmacol (1979) 0.82
Quantitative electroencephalographic evaluation of non-fatal and fatal traumatic coma. Electroencephalogr Clin Neurophysiol (1998) 0.82
Analysis of plasma trifluoperazine by gas chromatography and selected ion monitoring. J Chromatogr (1982) 0.81
Biphasic inhibition of stimulated endogenous dopamine release by 7-OH-DPAT in slices of rat nucleus accumbens. Br J Pharmacol (1995) 0.81
Serum lidocaine concentrations following application to the oropharynx: effects of cimetidine. Ther Drug Monit (1987) 0.80
Effects of sevoflurane on dopamine, glutamate and aspartate release in an in vitro model of cerebral ischaemia. Br J Anaesth (2001) 0.80
Gas chromatographic identification of thioridazine in plasma, and a method for routine assay of the drug. J Pharm Pharmacol (1969) 0.80
Fluphenazine decanoate trial in chronic in-patient schizophrenics failing to absorb oral chlorpromazine. Dis Nerv Syst (1973) 0.80
Gastric emptying in patients the day after cardiac surgery. Anaesthesia (1995) 0.79
In vivo folate kinetics during chronic supplementation of human subjects with deuterium-labeled folic acid. J Nutr (1992) 0.79
Drug distribution and effect. J R Coll Physicians Lond (1970) 0.79
Urinary excretion of chlorpromazine metabolites following single doses and in steady-state conditions. Res Commun Chem Pathol Pharmacol (1971) 0.78
Stability, human blood distribution and rat tissue localization of promazine and desmonomethylpromazine. Biopharm Drug Dispos (1990) 0.78
Late slow wave components of auditory evoked potentials: their cognitive significance and interaction. Electroencephalogr Clin Neurophysiol (1981) 0.78
Cimetidine interaction with amitriptyline. Eur J Clin Pharmacol (1985) 0.77
Evidence for modulatory effects of substance P fragments (1-4) and (8-11) on endogenous dopamine outflow in rat striatal slices. Neurosci Lett (1996) 0.77
Micro-extraction techniques in analytical toxicology: short review. Biomed Chromatogr (2006) 0.77
Pharmacokinetics of nitroglycerin and its metabolites after administration of sustained-release tablets. Biopharm Drug Dispos (1992) 0.77
Substance P-(1-7) and substance P-(5-11) locally modulate dopamine release in rat striatum. Eur J Pharmacol (1995) 0.77
Substance P fragments and striatal endogenous dopamine outflow: interaction with substance P. Neuropeptides (1998) 0.77
Early unwanted effects of fluphenazine esters related to plasma fluphenazine concentrations in schizophrenic patients. Psychopharmacology (Berl) (1985) 0.77
Contingent negative variation and slow waves in a short interstimulus interval go-nogo task situation. Ann N Y Acad Sci (1984) 0.77
Substance P modulation of striatal dopamine outflow is determined by M(1) and M(2) muscarinic receptors in male wistar rats. Neurosci Lett (2000) 0.77
Localization of basic drugs in the submaxillary gland. Biochem Pharmacol (1969) 0.77
Pharmacokinetics and pharmacodynamics of acepromazine in horses. Am J Vet Res (1994) 0.77
Are intraligamentary injections intravascular? Br Dent J (1993) 0.77
Preparation and stability of intravenous solutions of sodium dichloroacetate (DCA). J Parenter Sci Technol (1992) 0.77
Plasma nitroglycerin concentrations and hemodynamic effects of sublingual, ointment, and controlled-release forms of nitroglycerin. Clin Pharmacol Ther (1984) 0.76
Event-related potentials as indicants of structural and functional damage in closed head injury. Prog Brain Res (1980) 0.76
Unwanted effects of fluphenazine enanthate and decanoate. Lancet (1979) 0.76
Binding of temoporfin to the lipoprotein fractions of human serum. Br J Clin Pharmacol (1995) 0.76
Animal model for investigation of fluphenazine kinetics after administration of long-acting esters. Biopharm Drug Dispos (1981) 0.76
The strategy and value of neuroleptic drug monitoring. J Clin Psychopharmacol (1985) 0.76
Proceedings: A microsomal oxidase system in rat intestinal mucosa. Br J Pharmacol (1975) 0.75
Changes in reaction time and drug plasma concentrations after nitrazepam and glutethimide. Br J Clin Pharmacol (1977) 0.75